David A. Ebersman - 10 Jun 2021 Form 4 Insider Report for CASTLIGHT HEALTH, INC.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 10 Jun 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Jun 2021, 19:02:18 UTC
Prior SEC filing: 10 Aug 2021
Next SEC filing: 14 Jul 2021
Source filing: View source filing
Reporting owner signature: /s/ Mary Ahern, as attorney-in-fact

Key filing fact

David A. Ebersman filed Form 4 for CASTLIGHT HEALTH, INC. on 14 Jun 2021.

Key facts

This page summarizes David A. Ebersman's Form 4 filing for CASTLIGHT HEALTH, INC..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 14 Jun 2021, 19:02.

Change

Previous filing in this sequence was filed on 10 Aug 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CSLT transaction

Class B Common Stock

Award

Transaction value: $0
Shares: +70,707
Change %: +21%
Price: $0.000000
Shares after: 405,184
Date: 10 Jun 2021
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents an award of restricted stock units ("RSUs"). 25% of the RSUs will vest on August 16, 2021, and the remaining 75% of the RSUs will vest in 3 equal quarterly installments thereafter beginning on November 16, 2021. Each RSU represents a contingent right to receive one share of the Issuer's Class B common stock upon settlement for no consideration.